JAKARTA - Indonesian society needs various basic needs that accompany daily activities. In addition to the needs of clothing, food, and board which are the basic needs of humans, other needs are also needed, namely the need for pharmaceuticals.
Pharmaceutical needs are essential to maintain public health so that they have a healthy and strong immune system and are not easily infected with viruses. Medicines, medical devices, and special pharmaceutical needs such as vaccines are some of the pharmaceutical needs that are very necessary for the community.
However, because Indonesia has a very wide area from Sabang to Merauke and a large population, the distribution of pharmaceuticals is important to meet these needs.
CDOB is an abbreviation of Good Drug Distribution Method. Simply put, this is a way of distributing or distributing drugs and/or drug ingredients with certain principles to ensure their quality. In addition to ensuring that the distribution process is smooth and safe, CDOB can also be used as a tool to anticipate drug counterfeiting and the circulation of counterfeit drugs that can harm various parties who need the pharmaceutical ingredients.
In order to ensure that the drugs circulating in the community are of good quality and guaranteed authenticity, their distribution must be in accordance with the CDOB.
Based on Regulation of the Indonesian Food and Drug Administration Number 20 of 2025 concerning Standards for Good Drug Distribution, Pharmaceutical Wholesalers (PBF) are required to implement the CDOB standard. The implementation of the CDOB standard aims to maintain the consistency of the quality of drugs produced by the pharmaceutical industry throughout the distribution channel until it reaches the hands of consumers in accordance with the purpose of its use.
The CDOB certificate is a valid document that is proof that the PBF or PBF branch has met the requirements of the CDOB in distributing drugs and/or drug ingredients.
To ensure and ensure that the distribution and distribution of drugs and drug ingredients are in accordance with their requirements and objectives, BPOM requires PBF to have a CDOB Certificate, as revealed by the Director of Distribution and Service Supervision of Drugs, Narcotics, Psychotropic Substances, and Precursors (ONPP) Bayu Wibisono, S.Si, Apt, M.B.A. in the Public Consultation Forum on CDOB Certification Services held in Jakarta, Thursday (21/5/2026).
Improvement of CDOB Certification ServicesThe CDOB certificate is issued from the CDOB Certification process based on the submission of PBF and assessment of CDOB fulfillment by BPOM officers. The CDOB certification is a public service processed at the Directorate of Distribution and Service of Drugs, Narcotics, Psychotropic Substances, and Precursors.
Over time, and considering the importance of CDOB certification in ensuring the quality and quality of drugs and drug ingredients circulating in the community, the ONPP Distribution and Service Supervision Directorate has carried out a number of improvements in the certification process services.
One of them is by reducing the time or timeline in evaluating applications, documents, and CDOB requirements. Previously, the service time in evaluating CDOB applications required a maximum of 49 working days. In the last three years, the service only took an average of 31 working days, faster than the service commitment or Service Level Agreement (SLA) and will continue to be improved to accelerate this process.
However, the acceleration of time in evaluating the application of documents and CDOB requirements does not reduce the service standards of the ONPP Distribution and Service Supervision Directorate.
The reduction in time in evaluating the application is inseparable from the results of evaluation through the Public Consultation Forum (FKP) for the CDOB Certification Service Standard.
The Directorate of Distribution and Service Supervision of Drugs, Narcotics, Psychotropic Substances, and Precursors as the unit that organizes public services in the POM Agency is authorized to carry out the CDOB Certification service process, considering that constructive input, suggestions, and criticism from stakeholders are very needed as an effort to build a fair, transparent, and accountable public service system.
Director of Distribution and Service Supervision of ONPP Bayu Wibisono emphasized that the FKP was carried out with the aim of obtaining input from the public regarding the services provided by the Directorate of Distribution and Service Supervision of Drugs, Narcotics, Psychotropic Substances, and Precursors.
"This forum is also carried out as an effort to make continuous improvements, as well as monitoring and evaluating the public services that are held," he said.
Meanwhile, the Deputy for Drug, Narcotics, Psychotropic, Precursor and Addictive Substances Dr. William Adi Teja, MD., B.Med., M.Med. conveyed the direction that through collaboration between the government, business actors and the community, it is hoped that improvements and innovations in public services can be created. more effective, efficient, transparent, and able to optimally respond to the needs of the community and the business world.
Safe and Quality Medicine GuaranteeThe public has the right to access health facilities and support to obtain a better quality of life. This also includes access to pharmaceutical supplies such as medicines and drug ingredients.
With the CDOB certification, the public has certainty that the drugs they get are quality famasi preparations and are guaranteed to be authentic.
In addition, CDOB certification can also increase the competitiveness of business actors, the trust of the Pharmaceutical Industry (principal), the trust of regulators, the trust of Pharmaceutical Service Facilities (Pharmacies, Hospitals, and Clinics), and the success of the National Health Insurance (JKN) program in order to protect the community. This means that CDOB certification is not only beneficial for the community but also for business actors.
Thus, the PBF can provide assurance that the drugs consumed by the public remain safe, beneficial, and of good quality as when the drugs are produced by the pharmaceutical industry in accordance with the Good Distribution of Medicines.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
